Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (121-130 of 225) with videos related to

Pageof 23
Sort By:
Scandinavian Journal of Immunology|August 20, 2015
Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor BlockadeM Mehling, A-V Burgener, V Brinkmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Towards a european network for multiple sclerosis trials (ENMST)L Kappos, C Polman, A J Thompson, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 23, 2009
Rigidity of retinal vessels in patients with multiple sclerosisA Kochkorov, K Gugleta, D Kavroulaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Computer assisted retraining of attentional impairments in patients with multiple sclerosisA M Plohmann, L Kappos, W Ammann, et al.
Neurology|January 6, 2009
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension studyP O'Connor, G Comi, X Montalban, et al.
Neurology|March 23, 2005
Interferon beta-1b treatment does not induce autoantibodiesC H Polman, L Kappos, F Dahlke, et al.
Acta Neurologica Scandinavica|June 15, 2013
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosisJ Kuhle, C Malmeström, M Axelsson, et al.
AJNR. American Journal of Neuroradiology|December 19, 2009
MR imaging in multiple sclerosis: review and recommendations for current practiceK-O Lövblad, N Anzalone, A Dörfler, et al.
The Journal of Clinical Investigation|February 1, 1993
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patientsA Valli, A Sette, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year resultsG Comi, P O'Connor, X Montalban, et al.
Pageof 23

Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
Scandinavian Journal of Immunology|August 20, 2015
Tissue Distribution Dynamics of Human NK Cells Inferred from Peripheral Blood Depletion Kinetics after Sphingosine-1-Phosphate Receptor BlockadeM Mehling, A-V Burgener, V Brinkmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2003
Towards a european network for multiple sclerosis trials (ENMST)L Kappos, C Polman, A J Thompson, et al.
Klinische Monatsblatter Fur Augenheilkunde|April 23, 2009
Rigidity of retinal vessels in patients with multiple sclerosisA Kochkorov, K Gugleta, D Kavroulaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 1998
Computer assisted retraining of attentional impairments in patients with multiple sclerosisA M Plohmann, L Kappos, W Ammann, et al.
Neurology|January 6, 2009
Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension studyP O'Connor, G Comi, X Montalban, et al.
Neurology|March 23, 2005
Interferon beta-1b treatment does not induce autoantibodiesC H Polman, L Kappos, F Dahlke, et al.
Acta Neurologica Scandinavica|June 15, 2013
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosisJ Kuhle, C Malmeström, M Axelsson, et al.
AJNR. American Journal of Neuroradiology|December 19, 2009
MR imaging in multiple sclerosis: review and recommendations for current practiceK-O Lövblad, N Anzalone, A Dörfler, et al.
The Journal of Clinical Investigation|February 1, 1993
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patientsA Valli, A Sette, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year resultsG Comi, P O'Connor, X Montalban, et al.
Pageof 23